Since its introduction in 1967, many authors in industrialized countries have reported excellent results in the treatment of gonorrhoea with a combination of trimethoprim and sulphamethoxazole (Csonka and Knight, 1967; Schofield, Moffett, Masterton, and McGill, 1969; Carroll and Nicol, 1970;  Ullmann, Niordson, and Zachariae, 1971; Siboulet, 1971 ; Rodin and Seth, 1972 ; van Dijk and Tan Lim, 1973) . Unsatisfactory results were reported by Wright and Grimble (1970) , and an intermediate result by Evans, Churcher, and Hluman (1972) . For developing countries, with their overwhelming demand for gonorrhoea treatment, few therapeutic studies are available. Arya, Pearson, Rao, and Blowers (1970) reported an unsatisfactory cure rate with low doses of trimethoprim-sulphamethoxazole (T-SM) but a high cure rate with higher doses. Kloosman (1972) reported excellent results with three different single-dose schedules of T-SM in South Africa. Arya and Bosa (1973) evaluated the efficacy of different penicillin schedules in Uganda.
The aim of this study is to evaluate the efficacy (a) of our standard gonorrhoea treatment in Rwanda: probenecid 1 g. by mouth followed after 1 hr by 4-8 m.u. procaine penicillin intramuscularly and (b) of trimethoprim-sulphamethoxazole* in two different treatment schedules: a single dose of eight tablets, and a dosage of twenty tablets spread over 4 days.
Material and methods
The trial took place from November, 1972 , until July, 1973 No attempt was made to obtain a follow-up of longer than 2 weeks because of the possibility of re-exposure and the high risk of re-infection.
The 28 recurrences within 2 weeks of follow-up were classified as failures or re-infections according to their history of re-exposure.
The cure rate was calculated in two different ways: (a) As the number of failures related to the total number treated. Those who did not return for follow-up can be accepted as being symptomatically cured, the Venereal Disease Consultancy of the Institute being the only facility for treatment in the area. (b) As the number of failures related to the number followed, excluding the re-infections (Arya and Bosa, 1973).
Results
The Table summarizes (B) T-SM two tablets in the morning and three in the evening for 4 days cured 91 -9 per cent. of patients, an intermediate rate.
(C) Probenecid 1 g. followed by procaine penicillin 4 8 m.u. cured 96 6 per cent. of patients.
There were no major reactions after T-SM therapy and only one person complained of minor gastrointestinal disturbance. There were also no reactions after the penicillin therapy and, although the injection of such a large volume must cause some discomfort, the treatment was readily accepted.
The Figure, giving the cumulative number of recurrences (failures plus re-infections) during the 2 weeks follow-up period, shows more clearly the respective efficacy of the three treatment schedules.
Of the fifty persons considered cured of gonorrhoea in Group A, two continued to have an urethral discharge (PGU); but of fourteen urine specimens examined 10 days after treatment, six showed a firstglass pyuria of 20 leucocytes or more in the centrifuged deposit ( x 400).
Of the 45 patients considered cured of gonorrhoea in Group B, no person remained with an urethral discharge, and 10 days after the end of treatment only three out of twelve examined had a first-glass pyuria of 20 leucocytes or more.
Of the 57 patients cured in Group C, three had a non-gonococcal urethral discharge, and six out of seventeen examined 10 days after treatment had a first-glass pyuria of 20 leucocytes or more. FIGURE Cumulative number of recurrences of gonorrhoea in patients receiving three different treatment schedules Two persons developed a primary syphilitic infection, one 6 days after a single dose of eight tablets of T-SM, and one 15 days after twenty tablets of T-SM. Discussion Probenecid 1 g. followed after 1 hr by 4-8 m.u. procaine penicillin is a highly effective treatment for gonorrhoea. Rodin and Seth (1972) in London, and Arya and Bosa (1973) (1971) with two doses of five tablets at an interval of 8 hours. Kloosman (1972) , however, claimed a 100 per cent. cure rate with single doses of eight, ten, or 12 tablets of T-SM.
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The 91 9 per cent. cure rate with the T-SM schedule of two tablets in the morning and three in the evening for 4 days is acceptable, and only slightly lower than that obtained, using a comparable total dose by Csonka and Knight (1967), Schofield and others (1969) , Carroll and Nicol (1970) , Arya and others (1970) , Siboulet (1971), Rodin and Seth (1972) , van Dijk and Tan-Lim (1973) , and Svindland (1973) . Only Wright and Grimble (1970) As Rodin and Seth (1972) recommended, when using a total dosage of twenty tablets it may be better to give the daily dose of four or five T-SM tablets once daily than to divide them in a twice or four times daily schedule.
Twenty tablets of T-SM is a useful second-line schedule of treatment; it is comparable with tetracycline, but has the advantage of fewer doses than the 6-day treatment with 1-5 g. tetracycline daily.
The lack of effect of T-SM on an incubating syphilitic infection (Svindland, 1973) was confirmed by the two cases of primary syphilis seen during the follow-up period.
An important consideration is that, in countries with a high incidence of infectious syphilis, the treatment used for gonorrhoea should either cure this also (as is the case with the high-dose procaine penicillin schedule) or should not influence it at all.
Summary
Probenecid 1 g. followed after 1 hr by 4-8 m.u. procaine penicillin, which is the recommended treatment for gonorrhoea in Rwanda, cured 96 6 per cent. of cases of acute gonorrhoea in men.
A single dose of eight tablets of trimethoprimsulphamethoxazole gave a less satisfactory cure rate of 83-4 per cent., while twenty tablets of trimethoprim-sulphamethoxazole, two in the morning and three in the evening for 4 days, cured 91 9 per cent. of patients.
Lack of effect of trimethoprim-sulphamethoxazole on incubating syphilis was confirmed by the development of primary syphilis in two patients during the 2-week follow-up period.
Traitement de la gonococcie par le trimethoprimesulfamethoxazole et par le probenecide plus la penicilline-procaine au Ruanda 
